General Information of the Compound
| Compound ID |
CP0922627
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-endo-(8-{2-[(4,4-difluorocyclohexylmethyl)-((S)-2,3-dihydroxy-propionyl)amino]ethyl}-8-azabicyclo[3.2.1]oct-3-yl)-benzamide trifluoroacetate salt
Show/Hide
|
||||||||||||||||||
| Formula |
C28H38F5N3O6
|
||||||||||||||||||
| Molecular Weight |
607.617
|
||||||||||||||||||
| Canonical SMILES |
NC(=O)c1cccc([C@H]2C[C@H]3CC[C@@H](C2)N3CCN(CC2CCC(F)(F)CC2)C(=O)[C@@H](O)CO)c1.O=C(O)C(F)(F)F
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H37F2N3O4.C2HF3O2/c27-26(28)8-6-17(7-9-26)15-30(25(35)23(33)16-32)10-11-31-21-4-5-22(31)14-20(13-21)18-2-1-3-19(12-18)24(29)34;3-2(4,5)1(6)7/h1-3,12,17,20-23,32-33H,4-11,13-16H2,(H2,29,34);(H,6,7)/t20-,21+,22-,23-;/m0./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
QFKNULUFQAANIK-OQPSBSBNSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01188, Kappa-type opioid receptor
Protein ID: PT01515, Mu-type opioid receptor